Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

West Pharmaceutical Services (WST)

West Pharmaceutical Services (WST)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 27,246,624
  • Shares Outstanding, K 74,080
  • Annual Sales, $ 2,147 M
  • Annual Income, $ 346,200 K
  • 60-Month Beta 0.97
  • Price/Sales 10.42
  • Price/Cash Flow 58.95
  • Price/Book 12.57
Trade WST with:

Options Overview Details

View History
  • Implied Volatility 42.38% ( +0.92%)
  • Historical Volatility 38.11%
  • IV Percentile 98%
  • IV Rank 91.46%
  • IV High 44.46% on 01/27/21
  • IV Low 20.04% on 07/29/21
  • Put/Call Vol Ratio 0.43
  • Today's Volume 334
  • Volume Avg (30-Day) 110
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 924
  • Open Int (30-Day) 1,029

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate 1.92
  • Number of Estimates 4
  • High Estimate 1.94
  • Low Estimate 1.90
  • Prior Year 1.34
  • Growth Rate Est. (year over year) +43.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
365.61 +0.60%
on 01/18/22
475.00 -22.57%
on 12/27/21
-76.72 (-17.26%)
since 12/21/21
3-Month
365.61 +0.60%
on 01/18/22
475.00 -22.57%
on 12/27/21
-54.43 (-12.89%)
since 10/21/21
52-Week
253.85 +44.89%
on 03/05/21
475.35 -22.63%
on 09/09/21
+68.12 (+22.73%)
since 01/21/21

Most Recent Stories

More News
Quest Diagnostics (DGX) Rides on Test Sales, Base Volume Gain

Quest Diagnostics (DGX) continues to benefit from rapidly increasing molecular diagnostic testing volumes, driven by the massive spread of the new COVID-19 variant.

CERN : 91.70 (+0.23%)
DGX : 137.72 (+0.40%)
WST : 367.80 (-1.55%)
APEN : 5.55 (-0.89%)
Here's Why You Should Retain Hologic (HOLX) Stock for Now

Investors are optimistic about Hologic (HOLX) given the strength in the diagnostics business and notable acquisition deals.

CERN : 91.70 (+0.23%)
HOLX : 70.63 (+1.12%)
WST : 367.80 (-1.55%)
APEN : 5.55 (-0.89%)
Here's Why You Should Hold on to Myriad Genetics (MYGN) for Now

Investors are optimistic about Myriad Genetics (MYGN), given robust volume growth for GeneSight and prenatal testing.

CERN : 91.70 (+0.23%)
MYGN : 26.53 (-0.90%)
WST : 367.80 (-1.55%)
APEN : 5.55 (-0.89%)
Phirbo's (PAHC) Rising Costs, Currency Headwind Ail Growth

Though Phirbo (PAHC) has raised prices on selective products, these increases do not fully compensate for the higher cost of freight and labor materials.

CERN : 91.70 (+0.23%)
WST : 367.80 (-1.55%)
PAHC : 19.95 (+0.76%)
APEN : 5.55 (-0.89%)
Here's Why You Should Hold on to National Vision (EYE) for Now

Investors are optimistic about National Vision (EYE), given new store growth for America's Best and Eyeglass World brands.

CERN : 91.70 (+0.23%)
WST : 367.80 (-1.55%)
APEN : 5.55 (-0.89%)
EYE : 37.86 (-0.42%)
Here's Why You Should Hold on to Globus Medical (GMED) for Now

Investors are optimistic about Globus Medical (GMED), backed by strength in the Enabling Technologies arm and ExcelsiusGPS platforms.

TMO : 580.33 (-1.33%)
MCK : 246.62 (-2.07%)
WST : 367.80 (-1.55%)
GMED : 67.93 (-1.28%)
Here's Why You Should Invest in Abbott (ABT) Stock Right Now

Riding on current business growth and bullish near-term prospects, Abbott (ABT) is worth investing in for now.

ABT : 125.83 (+0.90%)
CERN : 91.70 (+0.23%)
WST : 367.80 (-1.55%)
APEN : 5.55 (-0.89%)
Thermo Fisher (TMO) Hits a 52-Week High: What's Driving It?

Strength in end markets and significant contribution from COVID-response related revenues are driving Thermo Fisher's (TMO) top line.

CERN : 91.70 (+0.23%)
TMO : 580.33 (-1.33%)
WST : 367.80 (-1.55%)
APEN : 5.55 (-0.89%)
Omnicell (OMCL) Closes ReCept Holdings Acquisition Deal

Omnicell's (OMCL) completed buyout of the renowned specialty pharmacy management services provider is likely to bolster its Advanced Services offering.

CERN : 91.70 (+0.23%)
OMCL : 148.06 (-1.76%)
WST : 367.80 (-1.55%)
APEN : 5.55 (-0.89%)
Neogen (NEOG) Q2 Earnings Lag Estimates, Revenues Surpass

Robust segmental performance and contributions from StandGuard & Soleris product lines drove the top line for Neogen (NEOG) in the second quarter of fiscal 2022.

CERN : 91.70 (+0.23%)
WST : 367.80 (-1.55%)
NEOG : 35.03 (-2.15%)
APEN : 5.55 (-0.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

West Pharmaceutical Services, Inc. is a global drug delivery technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines...

See More

Key Turning Points

3rd Resistance Point 398.09
2nd Resistance Point 391.47
1st Resistance Point 379.63
Last Price 367.80
1st Support Level 361.17
2nd Support Level 354.55
3rd Support Level 342.71

See More

52-Week High 475.35
Fibonacci 61.8% 390.74
Last Price 367.80
Fibonacci 50% 364.60
Fibonacci 38.2% 338.47
52-Week Low 253.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar